Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human…
breast cancer
-
-
Cardiac risk in the treatment of breast cancer: assessment and management Antonis Valachis and Cecilia Nilsson Breast…
-
Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors:…
-
Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity: The CECCY Trial Avila MS, Ayub-Ferreira SM, de Barros Wanderley MR…
-
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores…
-
Cardiotoxicity of Aromatase Inhibitors in Breast Cancer Patients Jennifer Foglietta, Alessandro Inno, Francesca de Iuliis,…
-
Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer Jones LW, Habel LA, Weltzien…
-
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 3 2 factorial,…
-
Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study Gavila J, Seguí MÁ, Calvo…
-
Breast Cancer Therapy-Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based…